Bimini Health Tech Announces FDA 510(k) Clearance for Dermapose Access Office-Based Fat Harvesting System

SOLANA BEACH, Calif., April 29, 2020 /PRNewswire/ -- Bimini Health Tech announced today it received FDA 510(k) clearance for its novel fat harvesting system, Dermapose Access (K200168). The Dermapose Access enables safe, quick, and easy fat harvesting. Designed for office use, the launch of the Dermapose Access system creates a new product category focused on simplifying fat removal.

    --  Fat (adipose) removal through a small needle, not requiring an incision
        or stitch.


    --  Dermapose Access can be safely used in an office with only local
        anesthesia. Traditional fat removal (liposuction) takes place in an
        operating room.
    --  Dermapose Access complements our FDA cleared Dermapose Refresh microfat
        transfer system (K193363). When used together, both products are
        intended to make small volume fat transfer quick, safe, and easy. These
        innovations are aimed at filling the sizeable gap between powered
        liposuction fat grafting systems and hyaluronic acid (HA) injections
        popular with dermatologists.

"Dermapose Access overcomes one of the most challenging parts of fat transfer, safely removing fat," said Brad Conlan, CEO of Bimini Health Tech. "The product creates a totally controlled micro-environment for fat removal."

"The Dermapose products were developed with safety and ease of use in mind. With FDA clearance of Dermapose Access, alongside Dermapose Refresh, we have expanded our product portfolio to bring safe and easy fat transfer to new settings such as a dermatologists procedure room." Added Mr. Conlan, "It's now simple for patients seeking natural procedures to volumize and rejuvenate their appearance."

For information about Dermapose Access, please visit: www.hcp.dermapose.com/access/

To learn more about the entire Dermapose System, please visit: www.dermapose.com

ABOUT BIMINI HEALTH TECH

Bimini Health Tech is a global leader in the medical aesthetics market. The company develops and commercializes products that are elegant in their simplicity, yet impactful and proven in their aesthetic and therapeutic benefit. Since 2013, they have been developing innovative products to provide premium aesthetic care options to consumers and physicians alike. The Bimini Health Tech portfolio includes the brands Puregraft(®), Dermapose(®), and Kerastem(®).

View original content to download multimedia:http://www.prnewswire.com/news-releases/bimini-health-tech-announces-fda-510k-clearance-for-dermapose-access-office-based-fat-harvesting-system-301049086.html

SOURCE Bimini Health Tech